Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-molecular Heparin Infusion as Anticoagulation for Nocturnal Home Hemodialysis
NCT02957877Phase 4Unknown
- Sponsor
- Alice Ho Miu Ling Nethersole Hospital
- Start
- Mar 2016
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nadroparin in kidney disease (2 arms), sponsored by Alice Ho Miu Ling Nethersole Hospital. Primary endpoints: Prothrombin time at 8 hours, Activated partial thromboplastin time at 8 hours and 3 more. Status: unknown.
02
Drugs
nadroparin
03
Conditions
kidney disease
Beyond the preview
Go deeper on NCT02957877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957877.